查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1741130

腦下垂體癌市場：依癌症類型、依荷爾蒙類型、依治療類型、年齡層、依最終使用者、按地區

Pituitary Cancer Market, By Cancer Type, By Hormone Type, By Treatment Type, By Age Group, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

腦下垂體癌市場規模預計在 2025 年為 4.577 億美元，預計到 2032 年將達到 8.695 億美元，2025 年至 2032 年的年複合成長率為 9.6%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 4.577億美元
效能數據 從2020年到2024年 預測期 2025年至2032年
預測期：2025-2032年年複合成長率： 9.60% 2032年價值預測 8.695億美元

腦下垂體癌的病因尚不清楚；然而，遺傳和荷爾蒙失衡可能起著一定作用。大多數腦下垂體腫瘤是腺瘤，這意味著它們是非癌性的。腦下垂體癌的發生率低於腦下垂體囊腫，後者是良性的（非癌性的）。

腦下垂體癌的常見症狀包括頭痛、視力下降、體重減輕或無法增加體重、記憶力下降和注意力下降。某些類型的腦下垂體腫瘤會分泌過多的激素，導致庫欣氏症候群。這種疾病會導致催乳素分泌過量，使胸部和手臂皮膚變薄，腿部和臀部骨骼變得脆弱。即使女性沒有懷孕，它也會導致乳房分泌乳汁。此外，它還可能導致各種血壓變化，例如臉色潮紅以及手臂和腿部血壓升高。

市場動態：

腦下垂體瘤發生率的上升、研發投入的增加以及治療方法的技術進步預計將在預測期內推動全球腦下垂體癌市場的成長。此外，民眾認知度的提高也推動了對非侵入性治療的需求。提供腦下垂體瘤專科服務的醫院和診所數量的增加也推動了市場的發展。

然而，預計癌症治療的高成本是預測期內阻礙全球腦下垂體癌市場成長的主要因素。

本研究的主要特點

  • 本報告對全球腦下垂體癌市場進行了詳細分析，並提供了預測期 2025-2032（以 2024 年為基準年）的市場規模和年複合成長率(CAGR%)。
  • 它還揭示了各個領域的潛在商機，並說明了該市場的引人注目的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 它根據公司亮點、產品系列、關鍵亮點、績效和策略等參數，介紹了全球腦下垂體癌市場的主要企業概況。
  • 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
  • 全球腦下垂體癌市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員將透過用於分析全球腦下垂體癌市場的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
  • 發病率和盛行率不斷上升
  • 醫療圖像的進展
  • 加強研發
  • 個人化醫療需求日益成長
    • 限制因素
  • 缺乏認知和延遲診斷
  • 缺乏標準化的治療指南
  • 進行性腦下垂體癌的治療選擇有限
  • 藥物研發面臨的挑戰
    • 機會
  • 標靶治療開發
  • 聯合治療
  • 外科技術的進步
  • 新型診斷影像方法的開發
  • 影響分析
  • 主要亮點
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景

第4章腦下垂體癌市場-冠狀病毒（COVID-19）大流行的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

5. 腦下垂體癌市場（依癌症類型分類），2020 年至 2032 年

  • 腦下垂體腺瘤（良性腫瘤）
  • 腦下垂體癌（惡性腫瘤）

6. 腦下垂體癌市場（依荷爾蒙類型分類），2020 年至 2032 年

  • 催乳素瘤
  • 生長激素分泌腫瘤（肢端肥大症）
  • 促腎上腺皮質激素分泌腫瘤（庫欣氏症）
  • 甲狀腺刺激素分泌腫瘤（TSHomas）
  • 促性腺激素分泌分泌腫瘤

7. 腦下垂體癌市場（依治療類型分類），2020 年至 2032 年

  • 外科手術
  • 放射治療
  • 藥物治療（例如多巴胺促效劑、生長抑制素類似物、荷爾蒙補充療法）
  • 標靶治療
  • 化療

8. 腦下垂體癌市場（依年齡分類），2020 年至 2032 年

  • 孩子們
  • 成人

9. 腦下垂體癌市場（以最終用戶分類），2020 年至 2032 年

  • 醫院
  • 專科診所
  • 癌症治療中心
  • 研究機構

第 10 章 腦下垂體癌市場（按地區分類），2020 年至 2032 年

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東和非洲
  • GCC
  • 以色列
  • 北非
  • 中部非洲
  • 其他中東和非洲地區

第11章競爭格局

  • Novartis International AG
  • Pfizer Inc.
  • Ipsen Biopharmaceuticals, Inc.
  • Endocyte
  • RECORDATI GROUP
  • Camurus AB
  • Endeavor Biomedicines, Inc
  • Debiopharm International SA

第12章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI5851

Pituitary Cancer Market is estimated to be valued at USD 457.7 Mn in 2025 and is expected to reach USD 869.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.6% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 457.7 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.60% 2032 Value Projection: USD 869.5 Mn

The cause of pituitary cancer is not well understood. But genetics and hormonal imbalances may play a role. Most pituitary tumors are adenomas, or noncancerous. They are not as common as pituitary gland cysts, which are benign (noncancerous).

Symptoms of pituitary cancer often include headaches, vision changes, loss of weight or an inability to gain weight, and trouble with memory and concentration. Some types of pituitary tumors release too many hormones, which can lead to a disease called Cushing's syndrome. In some cases, this disease causes the body to produce too much prolactin, which can cause thinning of the skin in the chest and arms, and weak bones in the legs and feet. Other forms of this condition can cause the breasts to make milk, even when the person is not pregnant. The condition can also cause a wide range of changes in blood pressure, including a flushed face and high blood pressure in the arms or legs.

Market Dynamics:

Rising incidences of pituitary tumors, increasing investments in research and development activities, and technological advancements in treatment methods are expected to drive growth of the global pituitary cancer market during the forecast period. In addition, increased awareness among the populace has led to a higher demand for noninvasive treatments. The market is also driven by a rise in the number of hospitals and clinics that offer specialized services for pituitary tumors.

However, the high cost of cancer treatments is a major factor expected to impede the growth of the global pituitary cancer market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global pituitary cancer market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pituitary cancer market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Novartis International AG, Pfizer Inc., Ipsen Biopharmaceuticals, Inc., Endocyte, RECORDATI GROUP, Camurus AB, Endeavor Biomedicines, Inc., and Debiopharm International SA
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pituitary cancer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pituitary cancer market

Global Pituitary Cancer Market Detailed Segmentation:

  • By Cancer Type:
    • Pituitary Adenoma (Benign Tumor)
    • Pituitary Carcinoma (Malignant Tumor)
  • By Hormone Type:
    • Prolactinoma
    • Growth Hormone-Secreting Tumor (Acromegaly)
    • Adrenocorticotropic Hormone-Secreting Tumor (Cushing's Disease)
    • Thyroid-Stimulating Hormone-Secreting Tumor (TSHoma)
    • Gonadotropin-Secreting Tumor
  • By Treatment Type:
    • Surgery
    • Radiation Therapy
    • Medications (e.g., dopamine agonists, somatostatin analogs, hormone replacement therapy)
    • Targeted Therapy
    • Chemotherapy
  • By Age Group:
    • Pediatric
    • Adult
  • By End User:
    • Hospitals
    • Specialty Clinics
    • Cancer Treatment Centers
    • Research Institutes
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profile:
    • Novartis International AG
    • Pfizer Inc.
    • Ipsen Biopharmaceuticals, Inc.
    • Endocyte
    • RECORDATI GROUP
    • Camurus AB
    • Endeavor Biomedicines, Inc.
    • Debiopharm International SA

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Pituitary Cancer, By Cancer Type
    • Market Pituitary Cancer, By Hormone Type
    • Market Pituitary Cancer, By Treatment Type
    • Market Pituitary Cancer, By Age Group
    • Market Pituitary Cancer, By End User
    • Market Pituitary Cancer, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing Incidence and Prevalence
  • Advancements in Medical Imaging and Diagnostics
  • Increased Research and Development
  • Growing Demand for Personalized Medicine
    • Restraints
  • Limited Awareness and Delayed Diagnosis
  • Lack of Standardized Treatment Guidelines
  • Limited Treatment Options for Aggressive Pituitary Cancers
  • Challenges in Drug Development
    • Opportunities
  • Development of Targeted Therapies
  • Combination Therapies
  • Advancements in Surgical Techniques
  • Development of Novel Imaging Modalities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Pituitary Cancer Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Pituitary Cancer Market, By Cancer Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Pituitary Adenoma (Benign Tumor)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Pituitary Carcinoma (Malignant Tumor)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Pituitary Cancer Market, By Hormone Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Prolactinoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Growth Hormone-Secreting Tumor (Acromegaly)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Adrenocorticotropic Hormone-Secreting Tumor (Cushing's Disease)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Thyroid-Stimulating Hormone-Secreting Tumor (TSHoma)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Gonadotropin-Secreting Tumor
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

7. Pituitary Cancer Market, By Treatment Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Radiation Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Medications(e.g., dopamine agonists, somatostatin analogs, hormone replacement therapy)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Targeted Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Chemotherapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

8. Pituitary Cancer Market, By Age Group, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Adult
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

9. Pituitary Cancer Market, By End User, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Cancer Treatment Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

10. Pituitary Cancer Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2023and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021-2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • GCC
  • Israel
  • North Africa
  • Central Africa
  • Rest of Middle East & Africa

11. Competitive Landscape

  • Novartis International AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Ipsen Biopharmaceuticals, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Endocyte
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • RECORDATI GROUP
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Camurus AB
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Endeavor Biomedicines, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Debiopharm International SA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

12. Section

  • Research Methodology
  • About us